Unlocking the Potential of CCDC170: A Potential Drug Target and Biomarker

Target Name: CCDC170

NCBI ID: G80129

CCDC170

Unlocking the Potential of CCDC170: A Potential Drug Target and Biomarker

Protein-related diseases have long been a major focus in drug development due to their intricate mechanisms and the significant impact they have on human health. One such protein is CCDC170, a transmembrane protein that plays a crucial role in various physiological processes. CCDC170 is a protein that has been identified as a potential drug target and biomarker, making it an attractive target for researchers to explore. In this article, we will provide an overview of CCDC170, its functions, potential drug targeting, and its potential as a biomarker.

Overview of CCDC170

CDC170 is a 22-kDa transmembrane protein that is expressed in various tissues, including brain, heart, skeletal muscles, and placenta. It is characterized by a long N-terminus that contains a coiled-coil domain, which is responsible for its unique structure and function. The coiled-coil domain is responsible for the formation of a dimeric complex, which plays a critical role in various cellular processes, including cell signaling, DNA replication, and cell adhesion.

CDC170 is involved in several important cellular processes, including the regulation of cell adhesion, the establishment of tissue boundaries, and the regulation of cell signaling pathways. One of its most significant functions is its role in the regulation of cell-cell adhesion, which is critical for the development and maintenance of tissues and organs. CCDC170 has been shown to play a critical role in the regulation of tight junctions, which are a type of cell-cell adhesion that helps to maintain the integrity of tissues and organs.

In addition to its role in cell-cell adhesion, CCDC170 is also involved in the regulation of cell signaling pathways. It has been shown to play a critical role in the regulation of the TGF-β pathway, which is a well-known regulator of cell signaling pathways that is involved in the development and maintenance of tissues and organs. CCDC170 has been shown to play a critical role in the regulation of TGF-β signaling by regulating the activity of the transcription factor SMAD2.

Potential Drug Targeting

CDC170 has been identified as a potential drug target due to its involvement in several important cellular processes that are involved in the development and maintenance of diseases. One of the potential drug targets for CCDC170 is its role in the regulation of cell-cell adhesion, which is critical for the development and maintenance of tissues and organs.

CDC170 has been shown to play a critical role in the regulation of tight junctions, which are a type of cell-cell adhesion that helps to maintain the integrity of tissues and organs. tight junctions are critical for the regulation of ion and solute transport, as well as the regulation of cell signaling pathways. Therefore, drugs that can modulate tight junction formation and function could be an attractive drug targets for CCDC170.

Another potential drug target for CCDC170 is its role in the regulation of cell signaling pathways. CCDC170 has been shown to play a critical role in the regulation of the TGF-β pathway, which is a well-known regulator of cell signaling pathways that is involved in the development and maintenance of tissues and organs. Therefore, drugs that can modulate the activity of SMAD2, the transcription factor that regulates TGF-β signaling, could be an attractive drug targets for CCDC170.

Potential as a Biomarker

CDC170 has also been identified as a potential biomarker due to its unique structure and function. The coiled-coil domain of CCDC170 is responsible for its unique structure and function. The coiled-coil domain is capable of forming a dimeric complex, which is involved in several important cellular processes, including

Protein Name: Coiled-coil Domain Containing 170

Functions: Plays a role in Golgi-associated microtubules organization and stabilization

The "CCDC170 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC170 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets